Table 5 ROC curve analysis for maternal abdominal circumference measured prior the delivery as a predictor of selected maternal and foetal outcomes in the study group
The outcome | AUC (95% CI) | P | Cut-off value | Sensitivity | Specificity | OR (95% CI) for the outcome at the cut-off |
|---|---|---|---|---|---|---|
Composite adverse maternal outcome | 0.65 (0.61; 0.70) | < 0.001 | 100 cm | 74.4% | 49.6% | 1.38 (1.22; 1.57) |
Macrosomia | 0.63 (0.58; 0.68) | 0.0041 | 98 cm | 91.4% | 32.4% | 1.24 (1.12; 1.37) |
Neonatal hyperbilirubinemia | 0.58 (0.53; 0.63) | 0.033 | 108 cm | 35.5% | 79.0% | 1.46 (1.02; 2.09) |
Neonatal hypoglycaemia in the group with GDM | 0.80 (0.74; 0.85) | < 0.0001 | 103 cm | 88.9% | 60.3% | 2.01 (1.52; 2.64) |
Rare adverse neonatal outcome | 0.64 | 0.004 | 104 cm | 60.0% | 63.5% | 1.53 (1.14; 2.06) |